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Nicotinic acetylcholine receptors (nAChRs) containing 6 subunits are expressed in only a few brain areas, including midbrain
dopamine (DA) neurons, noradrenergic neurons of the locus ceruleus, and retinal ganglion cells. To better understand the regional
and subcellular expression pattern of 6-containing nAChRs, we created and studied transgenic mice expressing a variant 6
subunit with green fluorescent protein (GFP) fused in-frame in theM3-M4 intracellular loop. In6-GFP transgenicmice,6-dependent
synaptosomal DA release and radioligand binding experiments confirmed correct expression and function in vivo. In addition to strong
6* nAChR expression in glutamatergic retinal axons, which terminate in superficial superior colliculus (sSC), we also found6 subunit
expression in a subset of GABAergic cell bodies in this brain area. In patch-clamp recordings from sSC neurons in brain slices from
mice expressing hypersensitive 6* nAChRs, we confirmed functional, postsynaptic 6* nAChR expression. Further, sSC GABAergic
neurons expressing6*nAChRs exhibit a tonic conductancemediatedby standing activationof hypersensitive6*nAChRsbyACh.6*
nAChRs also appear in a subpopulation of SC neurons in output layers. Finally, selective activation of 6* nAChRs in vivo induced sSC
neuronal activation as measured with c-Fos expression. Together, these results demonstrate that 6* nAChRs are uniquely situated to
mediate cholinergic modulation of glutamate and GABA release in SC. The SC has emerged as a potential key brain area responsible for
transmitting short-latency salience signals to thalamus and midbrain DA neurons, and these results suggest that 6* nAChRs may be
important for nicotinic cholinergic sensitization of this pathway.
Introduction
Nicotinic acetylcholine receptors containing 6 subunits (6*
nAChRs) exhibit a unique expression pattern in the mammalian
brain. Using radiolabeled -conotoxin-MII, a cone snail toxin
selective for3/62* nAChRs,6* nAChRs have been localized
chiefly to ventral tegmental area (VTA) and substantial nigra pars
compacta (SNc) dopamine (DA) neurons, norepinephrine (NE)-
producing locus ceruleus (LC) neurons, and optic nerve axons
and their terminal areas (Whiteaker et al., 2000b; Champtiaux et
al., 2002; Gotti et al., 2005; Cox et al., 2008). Native 6* nAChRs
exhibit a variety of alternative stoichiometries. InDAneurons,6
subunits require 2 subunits (Salminen et al., 2004), but assem-
ble with and without 4 and 3 (Salminen et al., 2007; Drenan et
al., 2010). LC NE neurons likely produce both 64* and 62*
nAChRs (Le´na et al., 1999; Azam and McIntosh, 2006; Azam et
al., 2010). Retinal axons contain a variety of6* nAChRs, includ-
ing 4623*, 3462*, 362, and 623* (Cox et al.,
2008).
Studies of6*nAChR function in vivohave led to several impor-
tant findings. 6 knock-out (KO) mice have decreased nicotine-
stimulated DA release (Champtiaux et al., 2003) and acute
intravenous (IV) nicotine self-administration (Pons et al., 2008). IV
self-administration is restored by selective re-expression of 6 in
VTA (Pons et al., 2008). Chronic intracranial nicotine self-
administration is largely normal in 6 KO mice, but activity-
dependent DA release in striatum is perturbed in these animals
(Exley et al., 2011). In rats, VTA 6* nAChRs mediate the psy-
chomotor stimulant effect of systemic nicotine (Gotti et al.,
2010).Mice that express hypersensitive6* L9S nAChRs exhibit
spontaneous locomotor hyperactivity and nicotine-stimulated
locomotor activation at doses specific for 6* nAChRs (Drenan
et al., 2008a). These phenotypes likely arise from enhanced activity
of ventral midbrain DA neurons in response to 6* nAChR activa-
tion (Drenan et al., 2008a), and/or altered activity-dependent DA
release in striatum (Drenan et al., 2010).
DA neurons switch among tonic firing (1–5 Hz), phasic firing
(20–100Hz), and brief cessation of firing depending on the value
of received versus expected outcomes. Recently, it has been ap-
preciated that the superior colliculus (SC) sends excitatory pro-
jections tomidbrain DA neurons, influencing their firing activity
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and DA release in striatum (Comoli et al., 2003; Dommett et al.,
2005; May et al., 2009). CtxMII-sensitive (3* or 6*) nAChRs
are expressed at extremely high density in superficial layers of SC
(Whiteaker et al., 2000b; Champtiaux et al., 2002; Cox et al.,
2008). CtxMII-sensitive nAChRs were also detected postsynap-
tically in SC (Endo et al., 2005), but the subunit composition of
these receptors was not determined. To gain a better understand-
ing of 6* nAChR expression, we generated and studied a bacte-
rial artificial chromosome (BAC) transgenic mouse expressing a
variant 6 subunit with enhanced GFP fused in-frame in the
M3/M4 intracellular loop. Also, we recorded from SC neurons in
mice expressing a hypersensitive variant of themouse 6 subunit
(6 L9S). In these studies, we demonstrate high levels of expres-
sion of 6* nAChRs in the DA system, and we reveal new details
regarding 6* nAChR expression and function in mouse visual
system.
Materials andMethods
Materials. [ 3H]-dopamine was obtained from PerkinElmer (7,8-[ 3H] at
30–50 Ci/mmol). HEPES, free acid, and sodium salt were products of
Amresco. Ultra centrifugation grade sucrose was obtained from Fisher
Chemicals. Sigma-Aldrich was the source for the following compounds:
L()-arabinose, ascorbic acid, atropine sulfate, bovine serum albumin
(BSA), ()-nicotine tartrate, nomifensine, streptomycin, ampicillin,
chloramphenicol, kanamycin, tetracycline, and pargyline. Optiphase
“SuperMix” scintillation fluid was from PerkinElmer Life Sciences.
-Conotoxin MII was synthesized by previously described methods
(Azam et al., 2010).
BAC recombineering and transgenesis. 6 L9S mice were described
previously (Drenan et al., 2008a), and served as a model for creation of
6-GFP mice. BAC RP24–149I12 containing the mouse 6 nicotinic
receptor subunit gene (Chrna6 ) was obtained from the BACPAC Re-
source Center at Children’s Hospital Oakland Research Institute (Oak-
land, CA). BAC recombineering was performed using a Counter
Selection BAC modification kit (Genebridges). Recombineering in bac-
teria uses endogenous recombination activity, and allows the insertion of
exogenous DNA into the BAC without residual sequences such as selec-
tion markers (neo) or loxP sites. 6 wild-type (WT) was mutated to
6-GFP using a two-step selection/counter selection protocol, similar to
a previous study (Drenan et al., 2008a). First, a cassette containing a
tandem selection (neo)/counter selection (rpsL) marker was introduced
after the alanine at position 405, a previously tested insertion site for GFP
(Drenan et al., 2008b). The rpsL/neo cassette was amplified by PCRusing
oligos designed to engineer 6 exon 5 homology arms flanking the se-
quence through A405 and after A405. The oligo sequences were as fol-
lows: forward primer: 5-cc aaa ctt cta aag gaa tgc cac cac tgc caa aaa tca
agt gac ata gca gtcgacGGCCTGGTGATG ATGGCGGGA TCG-3 and
reverse primer: 5- tt ctc tgc cac cca ccg tgc agg ctg ctg gct tga tct tct ctt tcc
agg gtcgac TCA GAA GAA CTC GTC AAG AAG GCG-3 (homology
arms: lower case; SalI restriction site: underlined, lower case; rpsL/neo
cassette priming sequence: upper case).
Neo was used to select positive recombinants, and an engineered SalI
restriction site pair flanking the selection cassette was used to confirm the
location of the exogenously inserted DNAwithin the BAC. In the second
step, GFP was inserted and screened using counter selection. Bacterial
cells were placed under selective pressure (via streptomycin sensitivity
gained by insertion of the rpsL marker) to lose the neo-rpsL cassette and
replace it with a nonselectable GFP cassette. The GFP cassette was ampli-
fied by PCR using oligos containing the same 6 exon 5 homology arms
as the rpsL/neo cassette. Instead of a SalI restriction site, the GFP was
flanked with a small, three amino acid linker, A-G-A, that also contains a
KasI restriction site. The GFP cassette was amplified using the oligo
sequences: 5-cc aaa ctt cta aag gaa tgc cac cac tgc caa aaa tca agt gac ata
gca gct ggc gcc ATGGTGAGCAAGGGCGAGGAG-3 and 5- tt ctc tgc
cac cca ccg tgc agg ctg ctg gct tga tct tct ctt tcc agg ggc gcc tgc CTT GTA
CAGCTCGTCCAT (homology arms: lower case; A-G-A linker: under-
lined, lower case; GFP cassette priming sequence: upper case). The resul-
tant strain harbored a BAC with no ectopic DNA in or around the 6
gene. 6-GFP BACDNAwas confirmed to have the desiredmutation by
DNA sequencing, restriction mapping, and diagnostic PCR. The 6 nic-
otinic receptor gene is directly adjacent to the 3 nicotinic receptor gene
(Chrnb3). To eliminate the possibility that any physiological or behav-
ioral phenotypes of our transgenic mice could be attributed to the pres-
ence of extra copies of 3, but to retain the 3 locus, we silenced the 3
gene using homologous recombination. 3 was silenced by replacing
exon 1 (containing the methionine initiation codon) with an ampicillin
selection cassette. An ampicillinmarker derived frompCDNA3.1zeowas
amplified by PCR using oligos designed to engineer 3 homology arms
and diagnostic SbfI restriction sites flanking the ampicillin marker. The
oligo sequenceswere as follows: forward primer: 5-agc ctc aca aga cct gac
agc tca ctg ggc atc agt gaa gtg cac cctgcagg GAC GTC AGG TGG CAC-3
and reverse primer: 5-tga gag agt ggc act gag agc caa gaa gac ccg tag gaa
gcc tgt cctgcagg GTC TGA CGC TCA GTG-3 (homology arms: lower
case; SbfI restriction site: underlined, lower case; ampicillinmarker prim-
ing sequence: upper case). Two additional genes (4921537P18Rik and
Tex24 ), which are not expressed in brain, are also contained on the final
BAC construct.
Injection-grade 6-GFP BAC DNA was prepared via double CsCl
banding (Lofstrand Labs). To produce transgenic animals, BAC DNA
was injected into the pronucleus of fertilized B6D2F1 ova and implanted
into pseudopregnant Swiss-Webster surrogates. Several transgenic
founders were identified using tail biopsy DNA and PCR primers de-
signed to detect both the GFPmutation (forward: 5-ctc cgt tct gtc aag ctt
g-3, reverse: 5-acg agt gct ctg aat tct ctg-3), and the inserted ampicillin
cassette within the 3 gene (forward: 5-gct cat gag aca ata acc ctg-3,
reverse: 5-cag tct tgg aag caa cat cca gc-3). One transgenic line, “line 4,”
is reported in detail in this study. Founders were crossed to C57BL/6J
(The Jackson Laboratory) to obtain germline transmission and to estab-
lish a colony, and transgenic mice were continually backcrossed to
C57BL/6J. Routine genotyping was done by multiplex PCR (forward
primer #1: 5-tga tga tga gga aac ctc tgg-3; forward primer #2: 5-ctg ctg
ctc atc acc gag atc-3; reverse primer #1: 5-gtc gtg ctg ctt cat gtg gtc g-3;
and reverse primer #2: 5-cag atg tca ccc aag atg ccg-3) analysis of tail
DNA from newly weaned mice. 6-GFP BAC copy number was calcu-
lated using the comparative CT method following real-time PCR (Livak
and Schmittgen, 2001; Ballester et al., 2004; Lee et al., 2006; Schmittgen
and Livak, 2008), as previously described (Cohen et al., 2012). 6-GFP
transgenic mice contained six copies of the 6-GFP BAC.
Mice. All experiments were conducted in accordance with the guide-
lines for care and use of animals provided by the National Institutes of
Health (NIH), and protocols were approved by the Institutional Animal
Care andUseCommittee at PurdueUniversity, theCalifornia Institute of
Technology, or theUniversity of Colorado.Mice were kept on a standard
12 h light/dark cycle at 22°C and given food andwater ad libitum. OnP21,
mice were weaned and housed with same-sex littermates. At 21 to 28 d,
tail biopsies were taken for genotype analysis by PCR. Tails were digested
in 50mMNaOHat 95°C for 45min followed by neutralizationwith 0.5M
Tris-Cl, pH 5.5, and subsequent direct analysis by multiplex PCR.
Neurotransmitter release from synaptosomes. Previously described
methods were followed formeasuring DA release (Salminen et al., 2007).
Briefly, appropriate brain regionswere homogenized in 0.5ml of ice-cold
0.32M sucrose bufferedwith 5mMHEPES, pH7.5. A crude synaptosomal
pellet was prepared by centrifugation at 12,000  g for 20 min. The
pellets were resuspended in “uptake buffer” containing the following (in
mM): 128 NaCl, 2.4 KCl, 3.2 CaCl2, 1.2 KH2PO4, 1.2 MgSO4, 25 HEPES,
pH 7.5, and 10 glucose, supplemented with 1 ascorbic acid and 0.01
pargyline. After incubation at 37°C for 10 min, [ 3H]-DA (0.1 M) was
added and incubation continued for 5 min.
All superfusion experiments were conducted at room temperature
(RT) using methods described previously (Salminen et al., 2007;
McClure-Begley et al., 2009). In brief, aliquots of synaptosomes were
distributed onto filters and superfused with buffer (uptake buffer con-
taining 0.1% BSA and 1 M atropine with 1 M nomifensine) at 0.7
ml/min for 10 min, or buffer for 5 min followed by buffer with 50 nM
CtxMII. Aliquots of synaptosomes were then exposed to nicotine or
high potassium (20 mM) in buffer for 20 s to stimulate release of [ 3H]-
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DA, followed by buffer. Fractions (0.1 ml)
were collected for 4 min into 96-well plates at
10 s intervals, starting from 1 min before stim-
ulation, using a Gilson FC204 fraction collec-
tor with a multicolumn adapter. Radioactivity
was determined by scintillation counting using
a 1450 MicroBeta Trilux scintillation counter
(PerkinElmer Life Sciences) after addition of
0.15 ml Optiphase “SuperMix” scintillation
mixture. Instrument efficiency was 40%.
Perfusion data were plotted as counts per
minute versus fraction number. Fractions col-
lected before and after the peak were used to
calculate baseline as a single exponential de-
cay. The calculated baseline was subtracted
from the experimental data. Fractions that
exceeded baseline by 10% or more were
summed to give total released counts per
minute (cpm) and then normalized to base-
line to give units of release [(cpm-baseline)/
baseline] (Drenan et al., 2008a, 2010).
Agonist dose–response data were fit to the
Hill equation.
Patch-clamp electrophysiology. For slice elec-
trophysiology, transgenic and nontransgenic
mice were identified by genotyping new litters
at 14–18 d after birth. P17–P25 mice were
anesthetized with sodium pentobarbital (100
mg/kg; i.p.) followed by cardiac perfusion with
oxygenated (95% O2/5% CO2) ice-cold
glycerol-based artificial CSF (gACSF) contain-
ing the following in (mM): 252 glycerol, 1.6
KCl, 1.2 NaH2PO4, 1.2 MgCl2, 2.4 CaCl2, 18
NaHCO3, and 11 glucose. Following perfusion,
brains were removed and retained in gACSF
(0–4°C). Coronal slices (250 m) were cut
with amicroslicer (DTK-Zero 1; Ted Pella) at a
frequency setting of 9 and a speed setting of
3.25. Brain slices were allowed to recover for at
least 1 h at 32°C in regular, oxygenated ACSF
containing the following (in mM): 126 NaCl,
1.6 KCl, 1.2 NaH2PO4, 1.2 MgCl2, 2.4 CaCl2,
18 NaHCO3, and 11 glucose.
For recordings, a single slice was transferred
to a 0.8 ml recording chamber (RC-27L bath
with PH-6D heated platform; Warner Instru-
ments). Slices were continually superfused
with ACSF (1.5–2.0 ml/min) throughout the
experiment. Cells were visualized with an up-
rightmicroscope (FN-1; Nikon) using infrared
or visible differential interference contrast op-
tics. Patch electrodes were constructed from
Kwik-Fil borosilicate glass capillary tubes
(1B150F-4; World Precision Instruments) us-
ing a programmable microelectrode puller (P-
97; Sutter Instrument). The electrodes had tip
resistances of 4.5–8.0 M when filled with in-
ternal pipette solution (pH adjusted to 7.25
with Tris base, osmolarity adjusted to 290
mOsm with sucrose) containing the following (in mM): 135 K glu-
conate, 5 EGTA, 0.5 CaCl2, 2MgCl2, 10HEPES, 2Mg-ATP, and 0.1GTP.
Whole-cell recordings were taken at 32°C with an Axopatch 200B ampli-
fier, a 16-bit Digidata 1440A A/D converter, and pCLAMP 10 software
(all Molecular Devices Axon). Data were sampled at 5 kHz and lowpass
filtered at 1 kHz. The junction potential between the patch pipette and
the bath solution was nulled immediately before gigaseal formation. Se-
ries resistance was uncompensated.
To examine the function of somatic nAChRs, nicotine was locally
applied using a Picospritzer III (General Valve). Using a high-resolution
micromanipulator (Sutter Instruments), the pipette tip was moved
within 20–40 m of the recorded cell 1–2 s before drug application.
Nicotine-containing recording solution was then puffed at 10–20 psi for
250ms. Immediately after the application, the glass pipette was retracted.
Rb efflux from SC synaptosomes. Nicotine-stimulated Rb efflux
from SC was measured as described previously (Nashmi et al., 2007).
Briefly, SC was dissected from adult mice and crude synaptosomes pre-
pared as described above for neurotransmitter release. Each pellet was
resuspended in load buffer (140 mM NaCl, 1.5 mM KCl, 2 mM CaCl2, 1
mM MgSO4, 25 mM HEPES, and 22 mM glucose) and aliquots incubated
Figure 1. Production of6-GFP BAC transgenic mice and6* nAChR expression in visual system. A, Construction of6-GFP
BAC transgene. A BAC containing the full Chrna6 genewasmodified by recombineering to allow expression of a variant6 nAChR
subunit with GFP fused in-framewithin theM3–M4 intracellular loop.B, C,6* nAChR expression in retina.Whole-mount retinal
sectionswere prepared from6-GFP transgenicmice and stainedwith anti-GFP antibodies. GFP() cells in the GCLwere imaged
with confocalmicroscopy at 10 (B1), 60 (B2), and 480 (B3). Retinal cross sectionswere prepared from6-GFP transgenic
mice (C), followed by anti-GFP staining (brown color) and hematoxylin counterstaining to label nuclei.6 immunoreactivity was
confined to the GCL. D, E, 6* nAChR expression in visual thalamus and SC. Brains from 6-GFP transgenic mice were fixed,
sectioned at 50 m (coronal), and stained with anti-GFP antibodies. dLGN (D) and SC (E) stained positive for 6* nAChR
expression. PL, photoreceptor layer; ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner
plexiform layer.
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with 4 Ci of 86Rb for 30 min in a final volume of 35 l of load buffer.
Filters containing the synaptosomes loaded with 86Rbwere superfused
for 5 min with buffer (135 mM NaCl, 1.5 mM KCl, 5 mM CsCl, 2 mM
CaCl2, 1 mMMgSO4, 25 mMHEPES, 22 mM glucose, 50 nM tetrodotoxin
(TTX), and 0.1% BSA) and the effluent was pumped through a 200 l
Cherenkov cell and into a -Ram detector (IN/US Systems). Radioactiv-
ity wasmeasured for 3minwith a 3 s detectionwindowproviding 60 data
points for each superfusion. Each aliquot was stimulated by one of four
different nicotine concentrations, with a 5 s exposure for each
concentration.
Epibatidine binding to membranes.Membranes were prepared by pre-
viously described procedures (Whiteaker et al., 2000a) from SC, thala-
mus, striatum (caudate putamen and dorsal nucleus accumbens),
olfactory tubercle (OT), cortex, and ventral midbrain, by homogeniza-
tion in ice-cold hypotonic buffer (14 mM NaCl, 0.2 mM KCl, 0.2 mM
CaCl2, 0.1 mM MgSO4, and 2 mM HEPES, pH 7.5) using a glass-Teflon
tissue grinder. Particulate fractions were ob-
tained by centrifugation at 20,000 g (15 min,
4°C) and washed by resuspension and centrif-
ugation three times, then stored (in pellet form
under homogenization buffer) at 70°C until
use. Protein was quantified with a Lowry assay
using BSA as the standard.
Binding of [125I]-epibatidine was quantified
using methods previously described (Whiteaker
et al., 2000a). Incubations were performed in 96-
well polystyrene plates, in 30l of binding buffer
(144 mM NaCl, 1.5 mM KCl, 2 mM CaCl2, 1 mM
MgSO4, and 20mMHEPES, pH 7.5) with 200 pM
[125I]-epibatidine. Binding reactionswere termi-
nated by filtration of samples onto a single thick-
ness of polyethyleneimine-soaked (0.5% w/v in
binding buffer) GFA/E glass fiber filters (Gelman
Sciences) using an Inotech Cell Harvester. Sam-
pleswere subsequentlywashed six timeswith ice-
cold bindingbuffer. Bound ligandwas quantified
by gamma counting at 83–85% efficiency, using
a Packard Cobra counter. In experiments with
competitive unlabeledCtxMII (50nM), theme-
diumwas supplemented with BSA (0.1%w/v) as
a carrier protein. For cytisine inhibition, concen-
trations of 0, 50, or 150 nM were added to sepa-
rate wells and cytisine-sensitive and -resistant
bindingof [125I]-epibatidine calculatedusing the
equation B  [BH/(1([cyt]/IC50H)][BL/
(1([cyt]/IC50L)] where Bmeasured binding,
BH is binding with high affinity for cytisine, and
BL is binding with low affinity for cytisine with
respective IC50 values for inhibition of 200 pM
epibatidine experimentally determined (IC50H
3.5 nM; IC50L  290 nM). For all experiments,
nonspecific binding was determined in the pres-
ence of 1 mM ()-nicotine tartrate.
Immunohistochemistry, c-Fos induction, and
confocal imaging. Methods for immunohisto-
chemistry and confocal microscopy are similar
to previous studies (Drenan et al., 2008a). For
c-Fos experiments, mice were habituated to in-
jections with saline injections for 3–4 d before
the experimental injection. On the experimen-
tal day, mice were injected with nicotine (0.15
mg/kg; i.p.), and were perfused for immuno-
histochemistry 90 min later, as described
below.
Mice were deeply anesthetized with sodium
pentobarbital (100 mg/kg; i.p.) and perfused
transcardially with 15 ml of ice-cold PBS fol-
lowed by 25 ml of ice-cold 4% paraformalde-
hyde (PFA) in PBS. Brains were removed and
postfixed for 2 h at 4°C with the same fixative
and cryoprotected in PBS containing 30% sucrose until the brain sank.
Coronal or sagittal sections (50 m) were cut on a microslicer and col-
lected into a 12-well tissue culture plate containing PBS. Following ex-
traction from eye cups, several relief cuts were made on retinal tissue
sheets used for whole-mount analysis, and flattened retinal sections were
treated similarly to brain sections, as follows. Sections were permeabil-
ized (20 mM HEPES, pH 7.4, 0.5% Triton X-100, 50 mM NaCl, 3 mM
MgCl2, 300mM sucrose) for 1 h at 4°C followed by blocking (0.1%Triton
X-100, 5% donkey serum in TBS) for 1 h at RT. Slices were incubated
overnight at 4°C in solutions containing primary antibodies (diluted in
0.1% Triton X-100, 5% donkey serum in TBS). Primary antibodies and
final dilutions were as follows: 1:500 rabbit anti-GFP (A11122; Invitro-
gen), 1:500 sheep anti-tyrosine hydroxylase (TH; AB1542, Millipore),
1:500 mouse anti-GAD67 (MAB5406; Millipore), 1:500 mouse anti-
NeuN (clone A60, MAB377; Millipore), 1:500 guinea pig anti-VGLUT1
Figure 2. 6* nAChR expression in catecholamine-producing neurons. A, 6* nAChR expression in ventral midbrain DA
neurons. Coronal sections (bregma3.5 mm) were prepared from 6-GFP transgenic mice, followed by dual staining with
anti-GFP and anti- TH antibodies to label DA neurons. Sections were imaged with laser-scanning confocal microscopy, and fluo-
rescence from both channels (green, anti-GFP; red, anti-TH) were merged to indicate coexpression of6* nAChRs within TH()
neurons. B, 6* nAChR expression in LC NE neurons. Coronal sections (bregma 5.52 mm) from 6-GFP transgenic mice
containing LC were prepared and double stained as described in A. C, D, 6* nAChR expression in DA axons. Sagittal sections
(lateral 0.96 mm) containing medial forebrain bundle (MFB) DA axons were prepared from 6-GFP transgenic mice (C) and
nontransgenic controlmice (D). Sectionswere stained for GFP and TH as inA andB. GFP and TH channelsweremerged, and yellow
indicates 6-GFP staining within TH() DA axons. E, F, 6* nAChR expression in DA terminals in striatum. Coronal sections
(bregma0.14 mm) from 6-GFP transgenic mice (E) and nontransgenic control mice (F ) containing dorsal striatum were
prepared, stained for GFP and TH, and imaged as above. Yellow indicates 6-GFP staining within TH() DA terminals. CPu,
caudate putamen.
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(AB5905;Millipore), and 1:400 rabbit anti-c-Fos (sc-52; Santa Cruz Bio-
technology). Sections were washed three times for 10 min each in TBST
(0.1% Triton X-100 in TBS) and incubated for 1 h at RT with secondary
antibodies (diluted in 0.1% Triton X-100, 5% donkey serum in TBS).
Secondary antibodies and final dilutions were as follows: 1:1000 goat
anti-rabbit Alexa 488 (A11008; Invitrogen), 1:1000 donkey anti-sheep
Alexa 555 (A21436; Invitrogen), 1:1000 donkey anti-mouse Alexa 555
(A31570; Invitrogen), and 1:1000 goat anti-guinea pig Alexa 555
(A21435; Invitrogen). Sections were then washed four times in TBST for
10min each. Sections that were costainedwith the nuclear dye,Qnuclear,
were incubated after the third TBST wash in 1:1000 Qnuclear Deep Red
Stain (Q10363; Invitrogen) in PBS for 20 min at RT followed by three 5
minwashes in PBS. All sectionsweremounted on slides and coverslipped
with Vectashield (Vector Laboratories), then imaged with a Nikon
(Nikon Instruments) C1 or A1 laser-scanning confocal microscope sys-
tem equipped with spectral imaging capabilities and a Prior (Rock-
land) remote-focus device. A Nikon Plan Apo 10 or 60 oil
objective was used, and pinhole diameter was 30 m. Sections were
imaged at 12-bit intensity resolution over 512  512 pixels at a pixel
dwell time of 2–4 s. Alexa 488 was excited with an argon laser at 488
nm, and Alexa 555 was excited with a yellow solid-state laser at 561
nm. Qnuclear was excited with a diode laser at 636 nm. Imaging was
performed using the Nikon DEES grating and spectral detector with
32 parallel photomultiplier tubes. Signal from dyes was unmixed
from background autofluorescence similar to our previous studies
(Briggs et al., 2006; Drenan et al., 2008a,b).
Immunohistochemistry on retinal cross sections was performed as
follows. Eyes were removed and fixed in 4% PFA in PBS, followed by
paraffin embedding and sectioning at 7 mwith a microtome. Epitopes
were retrieved with 1 mMNa citrate buffer (pH 6.0), followed by H2O2
treatment. Sections were blocked, incubated with anti-GFP antibodies
(1:200 dilution) for 60min at RT,washed, and incubatedwith anti-rabbit
horseradish peroxidase secondary antibodies (K4003, EnVision Sys-
tem; Dako) for 45 min at RT. Sections were reacted with diaminobenzi-
dine reagent for 5min at RT, rinsed, stained with hematoxylin for 3min,
rinsed, dehydrated with a graded alcohol series, cleared with xylene, and
coverslipped.
Statistics and data analysis. Physiology, neurochemistry, and real-time
PCRdata are reported asmean SEM. Statistical significance (p	 0.05)
was determined with a Student’s t test for continuous data meeting para-
metric assumptions for normality and equal variance. Neurochemistry
data were analyzed for significance by one-way ANOVA with Tukey’s
post hoc analysis.
Results
Production and characterization of BAC 6-GFP
transgenic mice
To faithfully express GFP-labeled 6* nAChRs, we selected a
BAC clone (RP24–149I12) containing the Chrna6 (6 nAChR)
locus. This BAC was used previously to successfully express hy-
persensitive 6 L9S nAChRs in their native brain regions. Using
a two-step selection/counter selection recombineering protocol,
a coding sequence for GFP was inserted in exon 5 of the Chrna6
gene within the coding sequence for the M3-M4 intracellular
loop following Ala 405 (Fig. 1A). 6-GFP receptors with this
mutation assemble appropriately with 4, 2, and 3 nAChR
subunits, are trafficked to the cell periphery, and their function in
electrophysiological assays is comparable to 42 nAChRs (Dre-
nan et al., 2008b; Xiao et al., 2011).
Using anti-GFP immunostaining, we characterized 6-GFP
expression in the CNS of 6-GFP BAC transgenic mice. Using
[125I]-CtxMII, which does not distinguish between 3* versus
6* nAChRs, investigators have concluded that 3* and/or 6*
nAChRs are expressed strongly in visual pathways such as retina,
optic nerve, visual thalamus (dorsal lateral geniculate nucleus,
dLGN), and SC.We noted strong expression of 6-GFP nAChRs
in retinal tissue using whole-mount preparations (Fig. 1B1).
Strong expression was noted in the retinal ganglion cell (RGC)
layer in this preparation (Fig. 1B2). In presumptive RGCs, 6-
GFP nAChRs were expressed throughout the cell periphery, and
were not concentrated on the cell surface (Fig. 1B3). To confirm
that 6* nAChRs are expressed in RGCs, we prepared retinal
cross sections and stained the tissue with anti-GFP antibodies.
6-GFP nAChRs were localized exclusively in the ganglion cell
layer (GCL) in these sections (Fig. 1C), where we noted 6-GFP
expression in 52  2% of cells in this layer (data not shown).
Additionally, 6-GFP nAChRs were strongly expressed in dLGN
in thalamus (Fig. 1D) and in SC (Fig. 1E). 6-GFP nAChRs were
also localized to optic tract axons, and to the medial terminal
nucleus of the accessory optic tract (data not shown). These re-
sults are consistent with previous reports using [125I]-CtxMII
autoradiography, and with studies in 6 KO mice (Whiteaker et
al., 2000b; Champtiaux et al., 2002).
Others have previously demonstrated robust expression of 6
nAChR mRNA in DA neurons in SNc and VTA, and in NE neu-
rons in LC (Le Nove`re et al., 1996; Le´na et al., 1999; Azam et al.,
2002). At the protein level in 6-GFP mice, we found robust
expression of 6-GFP nAChRs in these areas. Using dual anti-
GFP and anti-TH immunostaining, we show that 6* nAChRs
are specifically expressed in TH-expressing DA (Fig. 2A) or NE
(Fig. 2B) neurons in these brain regions. In VTA, 6 subunits
were expressed in 88  2% of TH() neurons, and in SNc, 6
subunits were expressed in 98  1% of TH() neurons (n  2
mice; data not shown). These results are highly consistent with
previous similar studies using 6 mRNA in situ hybridization
(Azam et al., 2002).We did not find expression of6* nAChRs in
TH() neurons in these areas. In parasagittal sections, we report
modest expression of 6* nAChRs in TH() fibers, presumably
Table 1. Expression levels of6* nAChRs in6-GFPmice determined by
radioligand binding assays

125I-Epibatidine binding Control 6-GFP
CX MII-res 63.3 8.2 55.0 9.5
CX MII-sens 2.0 2.2 0.2 0.9
TH MII-res 101.4 15.6 99.9 4.1
TH MII-sens 5.3 2.7 9.8 1.1
ST MII-res 45.6 4.9 42.5 2.4
ST MII-sens 7.1 0.9 10.5 0.8
OT MII-res 30.3 1.9 28.6 2.3
OT MII-sens 7.1 1.1 6.5 0.7
SC MII-res 73.2 13.0 81.7 6.1
SC MII-sens 15.1 1.8 12.7 7.3
vMBMII-res 81.7 6.8 87.1 7.6
vMBMII-sens 6.0 1.7 5.8 2.1
CX cyt-res 0.6 0.7 0.2 0.5
CX cyt-sens 65.9 1.0 55.4 0.8
TH cyt-res 4.3 1.8 5.0 1.4
TH cyt-sens 102.4 2.6 104.6 2.1
ST cyt-res 2.1 0.0 2.1 0.2
ST cyt-sens 47.5 0.3 52.3 0.0
OT cyt-res 3.8 0.6 4.3 0.5
OT cyt-sens 34.4 0.9 29.6 0.7
SC cyt-res 4.9 1.2 4.8 0.2
SC cyt-sens 79.0 2.0 86.9 0.8
vMB cyt-res 3.9 0.8 3.9 0.8
vMB cyt-sens 84.0 2.0 89.0 0.8
Each indicated brain region was dissected and the tissue was prepared for binding experiments as described in
Materials and Methods. Samples were labeled with 
125I-epibatidine with or without competition with excess,
unlabeledCtxMII or cytisine.CtxMII and cytisine-sensitive and -resistant components are shown. For all exper-
iments, data from groups of 6-GFP and control (nontransgenic) littermate mice were compared. CX, cortex; OT,
olfactory tubercle; SC, superior colliculus; ST, dorsal striatum; TH, thalamus; vMB, ventralmidbrain.Data (in fmol/mg
protein) are mean SEM (n 5 mice).
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DA axons projecting to striatum and other forebrain targets (Fig.
2C). Staining experiments in nontransgenic control mice (Fig.
2D) demonstrated that punctate 6-GFP expression (Fig. 2C)
was not a staining artifact. Axonal6 staining wasmore punctate
relative to TH staining (Fig. 2C), suggesting that 6* nAChRs
were contained within vesicles in axons. Immunoelectron mi-
croscopy will be required to determine whether 6* nAChRs are
expressed on the surface of DA axons, or only within these axons
during their transport to DA terminals. Finally, in 6-GFP mice,
we found modest 6* nAChR expression throughout striatum
(Fig. 2E). Similar to DA axons, 6* nAChR expression in stria-
tum was punctate, representing a subset of TH() axons/fibers
(Fig. 2E). We found little to no 6* expression in TH() struc-
tures in striatum, and staining experiments in striatal sections
from nontransgenic control mice (Fig. 2F) ruled out possible
staining artifacts as an explanation for our results.
To determine whether 6-GFP
nAChRs were distributed like WT 6
nAChRs in the brain, we analyzed
CtxMII-sensitive and -resistant as well
as cytisine-sensitive and -resistant epiba-
tidine binding in several brain regions of
6-GFP transgenic mice and their non-
transgenic littermates. In cortex, striatum,
OT, thalamus, SC, and ventral midbrain,
CtxMII-sensitive and -resistant epiba-
tidine binding were similar between 6-
GFP and nontransgenic control mice. No
significant differences in CtxMII-
sensitive or -resistant epibatidine binding
were noted between 6-GFP and non-
transgenic littermates in these brain re-
gions (Table 1). This result was interesting
given that 6-GFP transgenic mice pos-
sess six ectopic copies of the 6-GFP BAC
transgene, and is consistent with previous studies in 6 L9S
mice, where multiple copies of the mutant 6 BAC did not result
in increased 6* nAChRs as measured by radioligand binding
(Drenan et al., 2008a).
To determine whether functional responses typically attrib-
uted (partially or fully) to 6* are altered in 6-GFP mice, we
measured ACh-stimulated nAChR responses in Rb efflux and
DA release assays. We prepared membranes from SC tissue for
Rb efflux, which is a general assay of presynaptic nAChR func-
tion (Nashmi et al., 2007). 6-GFP Rb efflux responses were
indistinguishable from those of nontransgenic littermates of 6-
GFP mice. Both CtxMII-sensitive (Fig. 3A) and resistant Rb
efflux components were similar between these two genotypes at
0.3, 3, and 30 M ACh (Table 2). Next, we prepared synapto-
somes from dorsal striatum (ST) and OT and measured ACh-
stimulated DA release. nAChR-dependent DA release was not
altered in the 6-GFP mice, as there was no apparent difference
between 6-GFP and nontransgenic control mice in this assay.
For both ST and OT, both the CtxMII-resistant and -sensitive
(Fig. 3B,C) component of DA release (EC50 and Rmax) were un-
changed by expression of 6-GFP nAChRs (Table 2). These
nAChR binding and functional experiments suggest that6-GFP
nAChRs are functional, and that there is neither significant over-
expression nor defective function of 6* nAChRs in 6-GFP
BAC transgenic mice.
Presynaptic and postsynaptic 6* nAChR expression in SC
To further study 6* nAChR expression in SC, we imaged 6-
GFP expression at high resolution in6-GFPmice.6-GFPmice
reveal strong 6* nAChR expression in the superficial gray layer
of SC (Fig. 4A). In superficial SC (sSC), anti-GFP staining was
notably diffuse, presumably indicating dense localization on
axons and/or dendrites. Additionally, a population of neuro-
nal somata in sSC and intermediate layers of SC also stained
positive for 6-GFP, indicating the presence of several previ-
ously unappreciated 6* nAChR-expressing cell groups (Fig.
4A). Using anti-NeuN and anti-GFP double-staining, we deter-
mined that 13 2%of sSCneurons are6() (Fig. 4B).Double-
label results with a nuclear stain (Qnuclear) were similar (Fig. 4C;
data not shown). The location, size, and dendritic geometry of
6() neurons in sSC resembled sSC “horizontal cells” (Langer
and Lund, 1974). Using confocal microscopy, we created a
z-stack rendering of several 6() neurons in sSC. 6() sSC
neurons were generally fusiform in geometry, typically having
Figure 3. Normal6* nAChR function in6-GFP transgenic mice. A, Normal Rb efflux in6-GFP transgenic mice. A crude
synaptosomal pelletwas prepared from6-GFP and their nontransgenic littermates, followed by Rb loading and stimulation of
Rb efflux by ACh application. Rb efflux sensitive toCtxMII (which includes6-dependent efflux) is shown for 0.3, 3, and 30
MACh.B,C, NormalDA release in6-GFP transgenicmice. ST (B) andOT (C)weredissected from6-GFPand their nontransgenic
littermates, followed by preparation of synaptosomes. Synaptosomes were loaded with [ 3H]-DA and stimulated with a range of
ACh concentrations (10, 30, 100, and 300 nM and 1 and 3M) in the presence and absence ofCtxMII. Data were fitted to the Hill
equation, andCtxMII-sensitive concentration response curves are shown for ST (B) and OT (C).
Table 2. Functional measurements of nAChR activity in6-GFPmice
DA release Control 6-GFP
ACh
ST MII-res Rmax 12.61 0.51 12.04 1.20
ST MII-res EC50 1.01 0.09 1.12 0.32
OT MII-res Rmax 15.86 0.77 13.63 0.83
OT MII-res EC50 0.44 0.05 0.39 0.06
ST MII-sens Rmax 3.34 0.55 3.93 0.29
ST MII-sens EC50 0.18 0.05 0.23 0.04
OT MII-sens Rmax 4.32 0.52 4.86 0.75
OT MII-sens EC50 0.11 0.04 0.19 0.06
K
ST K (20 mM) 12.70 1.29 10.61 1.24
ST K (20 mM) 14.39 0.35 12.69 0.48
Rb Efflux (ACh)
SC MII-res (0.3M) 1.08 0.29 0.82 0.13
SC MII-res (3M) 3.04 0.54 2.26 0.56
SC MII-res (30M) 3.52 0.15 3.45 0.14
SC MII-sens (0.3M) 0.85 0.32 0.40 0.26
SC MII-sens (3M) 1.53 0.51 1.31 0.43
SC MII-sens (30M) 4.01 0.77 3.23 0.74
For the indicated measurement (Rb efflux and DA release), brain regions were dissected, synaptosomes were
prepared, and assays were conducted using ACh as agonist. For DA release, a range of ACh concentrations were
tested (or 20mM K as a positive control), results were fit to the Hill equation, and Rmax and/or EC50 values for ACh
were derived and are shown. K results are total response (units are cpm normalized to baseline). For Rb efflux,
three ACh concentrations (0.3, 3.0, and 30M) were tested, and peak responses for each concentration are shown.
For Rb efflux and DA release, CtxMII-sensitive and -resistant activity components are shown. For all experi-
ments, data from groups of 6-GFP and control (nontransgenic) littermate mice were compared. OT, olfactory
tubercle; SC, superior colliculus; ST, dorsal striatum. Data (units are cpm normalized to baseline) are mean SEM
(n 4–6mice).
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two or three primary dendrites that gen-
erally run tangentially to the surface of the
colliculus (Fig. 4D).
GAD67, aGABAergicmarker, is densely
expressed in superficial SC, including a
population of GABAergic interneurons
(Kaneda et al., 2008a). To further character-
ize6()neurons inSC,westainedcoronal
SC sections with anti-GAD67 antibodies
(Fig. 5A1). In sSC, we found modest to
strong expression of GAD67 in nearly all
6() neurons (Fig. 5A2, single arrows).
6* nAChR expression defined only a sub-
set of GAD67() neurons, however, as sev-
eral GAD67() neurons in sSC did not
express 6-GFP (Fig. 5A2, double arrows).
Interestingly, the punctate/diffuse expres-
sion pattern seen surrounding 6() neu-
rons in sSC did not colocalize with GAD67,
supporting the idea that thesepuncta are ax-
onal or presynaptic 6* nAChRs derived
fromglutamatergic RGCaxons. To support
this, we stained similar sections with anti-
VGLUT1 antibodies (Fig. 5B1). VGLUT1
expression in sSCwasmodest andpunctate,
and a substantial fraction of 6() puncta
also colocalized with VGLUT1 (Fig. 5B2,
single arrows). 6-GFP expression in inter-
mediate SC (iSC) was restricted to a small
number of neurons, and did not exhibit a
presynaptic expressionprofile similar to sSC
(Figs. 4A, 5C1).Unlike sSC6() neurons,
iSC 6() neurons were not GABAergic
(Fig. 5C2). Together, these results indicate
that 6* nAChR subunits exhibit both pre-
synaptic expression in glutamatergic axons
and postsynaptic expression in a neuronal
subpopulation in both the superficial and
intermediate layers of the SC.
Functional expression of 6* nAChRs
in GABAergic neurons
To determine whether 6* nAChRs are
functional in sSC GABAergic neurons, we
made whole-cell recordings from sSC
neurons in slices from mice expressing
hypersensitive 6 L9S* nAChRs. These
mutant receptors are 10- to 100-foldmore
sensitive to agonists than WT, allowing
for selective activation of 6* nAChRs
(Drenan et al., 2008a). In previous exper-
iments with 6 L9S* nAChRs expressed
in midbrain DA neurons, 1M nicotine is
sufficient to strongly activate an inward current only in neurons
from mutant mice (Drenan et al., 2008a). In coronal slices, we
locally applied nicotine (1 M) to visually identified voltage-
clamped neurons in the superficial layer of SC using a drug-filled
micropipette and a Picospritzer. In 13 of 21 recorded neurons in
6 L9S slices, we recorded inward currents (rise time	100 ms)
characteristic of nAChR responses (Fig. 6A). These responses
were blocked by CtxMII (100 nM) (Fig. 6A), suggesting that
they were mediated by 6* nAChRs. In 6 L9S neurons with
inward responses, the average peak amplitude of the nicotine-
induced currents was47 5 pA (Fig. 6B). Responses to 1 M
nicotine in these neurons were specific to the 6 L9S genotype,
as we recorded no detectable responses to 1 M nicotine in non-
transgenic control slices (Fig. 6B,C). Higher concentrations of
nicotine (100M) were required to elicit similar responses in sSC
neurons from control slices (Fig. 6C). Responses to 1Mnicotine
in the remaining eight neurons from L9S slices were either non-
existent or small but complex responses with inward and out-
ward components (data not shown). We recorded 6* nAChR-
mediated responses in a higher fraction of recorded neurons in
Figure 4. 6* nAChR expression in sSC neurons. A,6* nAChR expression in a GFP-stained coronal section (bregma4.16
mm) from6-GFP transgenic mice is shown next to a diagram of the SC (Paxinos and Franklin, 2001).6* nAChR expression is
limited to the zonal layer (Zo), the superficial gray layer (SuG), and intermediate gray layer (InG). B, C,6* nAChRs are expressed
in a subset of neurons in sSC. In B, SC coronal sections were double stained with anti-GFP and anti-NeuN antibodies, followed by
laser scanning confocal imaging. Individual GFP andNeuN channels and amergemicrograph are shown, at 60magnification. In
C, similar sections were double stained with anti-GFP antibodies and a nuclear stain, followed by confocal imaging as in B, D,
Z-stack rendering of6() neurons in sSC. Two6() neurons in sSC were imaged with confocal microscopy and a 3D volume
render of the cell body and its processeswas created following serial Z-sectioning through the neuron. Op, optic nerve layer; InWh,
intermediate white layer; DpG, deep gray layer; DpWh, deep white layer.
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6 L9S mice than we expected based on fluorescent neurons in
6-GFP mice. We often selected larger cells when searching for
healthy neurons from which to record in sSC, and 6 nAChR
subunits may be selectively present in larger sSC neurons. Alter-
natively, 6() neurons in sSC may be intrinsically healthier
than 6() sSC cells, allowing them to preferentially survive the
slicing procedure.
To further characterize 6() neurons in sSC, we recorded sev-
eral voltage-clamp and current-clamp responses in these cells.
6() sSC neurons had an average resting membrane poten-
tial of 56  4 mV, and typically did not fire spontaneous
action potentials. In response to depolarizing current injec-
tions of20 to40 pA, 6() neurons fired action potentials
at 20–40 Hz (Fig. 6D). In response to hyperpolarizing current
injections, typical 6() sSC neurons responded with a small
but distinct and rapid adaptation in its membrane potential
(Fig. 6D). This voltage “sag” is characteristic of expression of
Ih currents. To determine whether these neurons express Ih
currents, we voltage clamped 6() neurons and recorded
current responses following hyperpolarizing voltage steps.
6() sSC neurons did express Ih currents (Fig. 6E), with a
maximum hyperpolarization-activated current of31 6 pA
during hyperpolarization to 120 mV (Fig. 6F).
6-dependent responses in 6() neurons could be due to
activation of somatodendritic nAChRs and cation influx
through nAChRs, or they may result from indirect activation
of cationic conductances. In our recording conditions, we
voltage clamp sSC neurons at 60 mV, and ECl is 83 mV.
As a result, GABAA receptor activation is unlikely to play a
major role in generating 6-dependent inward current re-
sponses. Furthermore, NMDA-dependent currents are an un-
likely contributor, as these channels are largely blocked by
intracellular Mg2 at 60 mV. To determine whether inward
current responses seen in 6() neurons
in slices from 6 L9S mice are mediated
by postsynaptic versus presynaptic
nAChRs,we treated sliceswith 6-cyano-7-
nitroquinoxaline-2,3-dione (CNQX; 20
M) to inhibit fast excitatory glutamater-
gic transmission. In the presence of
CNQX, the amplitude and duration of
nicotine-evoked currents were largely un-
changed relative to control, suggesting
that presynaptic AMPA receptors do not
play a role in generating inward currents
in 6() neurons (Fig. 7A, upper and
middle trace). Next, we blocked voltage-
gatedNa channels with TTX (0.5M) to
eliminate synaptic activity requiring ac-
tion potentials. In the presence of CNQX
and TTX, inward current responses in
6() neurons remained largely unal-
tered, again suggesting a direct cation in-
flux through nAChRs is responsible for
the inward current responses seen in our
slice preparations (Fig. 7A, bottom trace).
6() neurons in sSCwere often char-
acterized by a tonic membrane conduc-
tance that was apparent when voltage-
clamped at 60 mV (Fig. 7B, upper
trace). This enhancedmembrane conduc-
tance was absent in 6() sSC neurons
from6 L9Smice (Fig. 7B, middle trace),
and was similarly absent in sSC neurons from nontransgenic
slices expressing inward nAChR-mediated currents (Fig. 7B, bot-
tom trace). Indeed, in 6 L9S sSC neurons, there was an in-
creased noise in the voltage-clamp record in 6() neurons
compared with6() neurons (Fig. 7C). These currents lacked
the waveform of typical EPSCs or IPSCs that are generated via
point-to-point synaptic transmissionmechanisms, andwere sug-
gestive of volume transmission via ACh. These tonic membrane
currents were largely unaffected by treatment of slices with
CNQX and TTX (Fig. 7D, upper and middle trace). Tonic mem-
brane currents in sSC 6() neurons were completely blocked,
however, byCtxMII (Fig. 7D, bottom trace). Bath application of
hemicholinium-3 (HC-3; 50 M), which blocks choline uptake
into cholinergic presynaptic terminals and results in elimination
of ACh release, was sufficient to eliminate tonic membrane cur-
rents in sSC6() neurons (Fig. 7E; n 2, representative results
shown). These results in 6 L9S slices, where 6* nAChR cou-
pling to locally released ACh is exaggerated, suggest thatWT 6*
nAChRs in sSC neurons are strongly activated by tonic or phasic
ACh. 6* nAChR activation by ACh may increase GABA release
in sSC to influence processing of visual information.
To confirm in vivo that 6* nAChRs are expressed in sSC
neurons, we measured c-Fos induction in this brain area follow-
ing intraperitoneal injections of nicotine. 6 L9S and nontrans-
genic control littermate mice were injected with saline, or a dose
of nicotine (0.15mg/kg; i.p.) that selectively induces a behavioral
effect in L9S mice but not control mice (Drenan et al., 2008a,
2010). At this dose, nicotine robustly induced c-Fos expression in
6 L9S sSC, which was not the case in nontransgenic control
mice (Fig. 8A). Saline injections in nontransgenic control mice
and L9S mice resulted in similar levels of c-Fos expression com-
pared with nontransgenic control mice injected with nicotine
(Fig. 8A). We sampled and quantified c-Fos expression at several
Figure 5. Transmitter phenotypes of6() neurons in SC.A,6* nAChRs are expressed in GABAergic neurons in sSC. Coronal
sections from6-GFP transgenicmice containing sSCwere double stainedwith anti-GFP and anti-GAD67 antibodies, followed by
confocal microscopy. A2, Represents the boxed area in the A1 image. Single white arrows indicate cells coexpressing6* nAChRs
andGAD67,whereasdoublewhite arrows indicate cells expressingonlyGAD67.B,6*nAChRs are also expressed inglutamatergic
fibers in sSC. Coronal sections from6-GFP transgenic mice containing sSC were double stained with anti-GFP and anti-VGLUT1
antibodies, followed by confocal microscopy. B2, Represents the boxed area in the B1 image. White arrows indicate colocalized
VGLUT1 and6* nAChRs. C, iSC6() neurons are not GABAergic. Coronal sections from6-GFP transgenicmice containing iSC
were double stainedwith anti-GFP and anti-GAD67 antibodies, followed by confocalmicroscopy. C2, Represents the boxed area in
the C1 image.
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points across the anterior to posterior ex-
tent of the sSC. c-Fos induction was sig-
nificantly higher within the 6 L9S line
when we compared saline versus nicotine
(0.15 mg/kg) (6 L9S, nicotine: 12.3 
104 c-Fos() cells/m2;6 L9S, saline:
7.1  104 c-Fos() cells/m2; p 	
0.0001) (Fig. 8B). There was no signifi-
cant difference in c-Fos induction/expres-
sion within nontransgenic control mice
when we compared saline versus nicotine
(nontransgenic, nicotine: 5.7  104
c-Fos() cells/m2; nontransgenic, sa-
line: 6.0 104 c-Fos() cells/m2; p
0.68) (Fig. 8B). Togetherwith our electro-
physiology results from 6 L9S mice,
these results support the idea that 6*
nAChRs function in sSC, and that activa-
tion of these nAChRs can influence neu-
ronal excitability.
Discussion
Previous pioneering studies on nAChR
expression in visual and DAergic areas
have often relied on radiolabeled probes
such as CtxMII and epibatidine (White-
aker et al., 2000a,b, 2002). Because
CtxMII does not discriminate well be-
tween 6* nAChRs and 3* nAChRs,
there remain uncertainties about which
nAChR subtypes are most important
without concomitant use of other tools
that help amplify or isolate the function of
particular nAChRs. Here, we have used a
new transgenic reportermouse expressing
GFP-labeled 6 nAChR subunits to map
6* nAChR expression at high resolu-
tion. We demonstrate conclusively that
6* nAChR subunits exhibit a specific
expression pattern in the mouse visual
system, including expression in a subset of RGCs, a striated, presyn-
aptic expression pattern in visual thalamus, and dense presynaptic
and postsynaptic expression in superficial and intermediate/deep
layers of SC. 6* nAChRs, as we and others have previously sug-
gested (Le Nove`re et al., 1996; Le´na et al., 1999; Azam et al., 2002;
Drenan et al., 2008a), are specifically expressed in cell bodies, axons,
and presynaptic terminals of catecholamine-producing neurons in
the ventral midbrain (SNc/VTA) and dorsal pons (LC).
Our data demonstrating expression of 6* nAChRs in retinal
cells and retinal axons are consistent with previous findings, in-
cludingmRNA in situ hybridization studies (Moretti et al., 2004),
eye enucleation experiments (Gotti et al., 2005), and studies on
6KOmice (Champtiaux et al., 2002; Gotti et al., 2005). Our6*
nAChR expression data in the retina, where only52% of GCL
neurons (presumptive RGCs) express 6* nAChRs, suggests that
6* nAChRs perform a specific function(s) in one or more sub-
sets of RGCs, rather than a uniformmodulation of RGCs. This is
consistent with recent evidence detailing numerous subpopula-
tions of RGCs, each with unique features (Kim et al., 2010; Kay et
al., 2011). Direction-selective RGCs express several nAChR sub-
types (Strang et al., 2007), and 6* nAChRs may be expressed in
some or all of these cells.We did not find significant expression of
6 subunits in putative RGC dendrites in the inner plexiform
layer (Fig. 1C). Together with strong expression in optic nerve
axons, these data suggest that retinal-derived 6* nAChRs may
be selectively targeted to axons and/or presynaptic terminals.
Dense yet specific expression of 6* nAChRs on a subset of reti-
nal axons and/or glutamatergic presynaptic terminals in retino-
recipient areas suggests that 6* nAChRs mediate cholinergic
sensitization of specific visual signals, such as subsecond changes
in contrast or the appearance of novel objects in the visual field.
Previous studies using [125I]-CtxMII to detail3/6 nAChR
binding and expression in retinorecipient structures such as
dLGN and SC were not—due to the inherently low resolution
provided by radiolabeled probes—able to resolve somatic expres-
sion of 6 versus dense localization in presynaptic structures.
Our data using GFP-labeled 6 nAChR subunits coupled with
high-resolution confocal microscopy confirm that 6* nAChRs
are expressed not only in glutamatergic RGC axons (Fig. 5B), but
in a particular cell population in sSC (Fig. 4). A previous report
indicated that eye enucleation reduced 6* nAChRs in SC by
91% and 3* nAChRs by 92% (Gotti et al., 2005). The residual
6* nAChRs in these experiments could correspond to the post-
synaptic sSC 6* nAChRs we describe here. The pattern of so-
matic6* nAChR expression in sSC and iSC is nearly identical to
mRNA in situ hybridization data available for 6* and 3*
Figure6. 6*nAChRs function in sSCneurons.A,6-dependentnicotinic currents in sSCneurons. Coronal sliceswereprepared
from6 L9S transgenicmice, and sSC neuronswere studiedwith patch-clamp electrophysiology. sSC cells recorded inwhole-cell
modewere stimulatedwith nicotine (1M) to activate nAChRs. Responses to 1Mnicotinewere sensitive to blockade byCtxMII
(lower current trace). A representative response is shown. Scale bar, 25 pA; 1 s.B, Quantification of peak nicotine-evoked currents
in sSC neurons. Peak nicotine-elicited (1Mnicotine) currents fromeach sSC neuron in nontransgenic control or6 L9S slices are
plotted. C, Higher nicotine concentrations are required to activate nAChRs in nontransgenic control sSC neurons. sSC neurons in
nontransgenic control slices did not respond to 1M nicotine but respondedwith typical nAChR inward currents when stimulated
with 100 M nicotine. Scale bar, 20 pA; 1 s. D, Firing responses of sSC 6() neurons. sSC neurons from 6 L9S slices that
respond to 1M nicotine were recorded in current-clamp mode. Membrane potential was recorded in response to depolarizing,
zero, or hyperpolarizing current injections. Representative traces are shown, and the average resting membrane potential for all
studied6() sSC neurons is indicated. Scale bar, 30 mV; 400 ms. E, Ih current in6() sSC neurons. The same group of cells
analyzed in D were held in voltage-clamp mode at60 mV, and membrane currents were recorded during hyperpolarizing
voltage steps (60mV,70mV,80mV,90mV,100mV,110mV, and120mV). Representative traces are shown.
Scale bar, 40 pA; 300ms. F, Current-voltage relations for Ih currents shown in E. Peak current changesweremeasured immediately
before the end of each hyperpolarizing pulse. Data are mean SEM. ***p	 0.0001.
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nAChR subunits from the Allen Brain Atlas (www.brain-map.
org). sSC GABAergic 6() neurons are fusiform in shape with
two or three primary dendrites (Fig. 4D), were found within 200
m of the surface of the colliculus, and were characterized by a
modest Ih current (Fig. 6E,F). These characteristics correspond
best to sSC horizontal cells (Langer and Lund, 1974; Endo et al.,
2003, 2008), which are GABAergic interneurons. This suggests
that 6* nAChR activity may be important for shaping transmis-
sion of visual information as it proceeds from the optic nerve to
the output layers of the SC. A previous report demonstrated
agonist-evoked inward and outward currents in sSCneurons that
were attributed to several nAChR subtypes. Putative horizontal
cells in sSC often had CtxMII-sensitive components to their
inward current responses, implicating 6 and/or 3 nAChRs
(Endo et al., 2005). Outward currents in other sSC neurons,
which were partially mediated by presynaptic facilitation of
GABA release, were also blocked by CtxMII (Endo et al., 2005).
These results, together with our data, suggest an important role
for 6* nAChRs in shaping GABAergic transmission in sSC.
42* and 62* nAChRs are critical regulators of nicotinic
cholinergic transmission in the DA system, but is there a mean-
ingful connection between DA transmission and visual process-
ing? In awake behaving cats, Horvitz and et al. (1997) reported
the production of phasic DA neuron firing in response to non-
conditioned visual stimulation. The phasic responses in DA neu-
Figure 7. 6* nAChRs in sSC neurons are postsynaptic and respond to ambient ACh. A,
Whole-cell nAChR responses in6() neurons are postsynaptic. Responses to 1Mnicotine in
6 L9S sSC neurons were tested for sensitivity to CNQX (20M) and CNQX plus TTX (0.5M).
Scale bar, 20 pA; 2 s. B, Holding currents in 6() sSC neurons exhibits greater membrane
conductance fluctuations. sSC6(),6(), and nontransgenic neurons responding to 100
M nicotine were recorded in voltage-clamp mode. Representative voltage-clamp records
showingmembrane conductance fluctuations in the indicated cell type are shown. Scale bar, 6
pA; 600 ms. C, Quantification of membrane conductance fluctuations in 6 L9S 6() and
6() sSC neurons. Average root mean square noise for voltage-clamp membrane currents
recorded in sSC neurons identified as 6() or 6() is shown. Data are mean SEM. A
Student’s t test was used to compare6() and6() RMS noise. **p	 0.01.D, Increased
membrane conductance fluctuations in6() sSC neurons is blocked byCtxMII. Identified
6() sSC neurons in 6 L9S slices were recorded in voltage-clamp mode, and membrane
conductance fluctuations were observed in the presence of CNQX, CNQX plus TTX, or CtxMII
(100 nM). Scale bar, 6 pA; 600ms. E, Membrane conductance fluctuations in a6() sSC neurons
are eliminated by inhibition of ACh release. 6() sSC neurons were recorded as in D, and
membrane conductance fluctuations were observed in the presence of HC-3 (50M) and after
drug washout. A representative experiment (n 2) is shown.
Figure 8. Activation of sSC6* nAChRs in vivo. A, Induction of c-Fos expression following
nicotine injections in control and6 L9S mice. Mice of the indicated genotype were injected
with saline or nicotine (0.15mg/kg; i.p.), perfused, and brains were removed and sectioned for
anti-c-Fos staining. Representative sSC-containing brain sections stained with anti-c-Fos anti-
bodies are shown for control and 6 L9S mice. Scale bar, 50m. B, Quantification of c-Fos
staining. Images (n 10 for each genotype) of c-Fos-stained sSC brain sections, sampled from
multiple bregma levels,were analyzed for the number of c-Fos immunoreactive cells per square
micrometer of brain tissue. Results from saline and nicotine injections for control and6 L9S
mice are plotted. Data are mean SEM. A Student’s t test was used to compare saline versus
nicotine within mouse lines; ***p	 0.0001.
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rons occurred too rapidly (50–100 ms) to involve significant
processing by visual cortex, suggesting a subcortical route for
visual information to reach DA neurons. More recently, a direct
projection from intermediate and deep layers of SC to ventral
midbrainDAneurons has been described that likelymediates this
rapid response in DA neurons (Comoli et al., 2003; May et al.,
2009) and in downstream structures such as striatum (Dommett
et al., 2005). In addition to their roles encodingmotivation/value
and salience, DA neurons also respond to sensory events not
directly connected to reward or aversive experiences (Chiodo et
al., 1980; Steinfels et al., 1983; Strecker and Jacobs, 1985; Horvitz,
2000; Horvitz et al., 1997). These responses occur at short latency
(50–100 ms) and are strongest when the triggering stimulus is
unexpected (Schultz and Romo, 1990). The latency of these
sensory-evoked responses inDAneurons, alongwith the fact that
they preferentially respond to novel cues, is highly consistentwith
their being generated by the SC (Bromberg-Martin et al., 2010). It
is interesting that 6* nAChRs are not only expressed in presyn-
aptic and postsynaptic structures in sSC, but also in sparse non-
GABAergic cell bodies in iSC (Fig. 5C). Intermediate and deep
layers of SC receive input from and provide feedback to superfi-
cial SC (Katsuta and Isa, 2003; Endo et al., 2008; Kaneda et al.,
2008b; Phongphanphanee et al., 2011). These 6() neurons
may be among those that project directly to midbrain DA neu-
rons, and further studies are required to elucidate their function.
In light of this role of the SC in triggering DA neuron phasic
firing in response to an unexpected visual stimulus, it is interest-
ing that 6* nAChR expression is enriched in this pathway. Ex-
pression of 6* nAChRs in RGCs, the optic nerve, visual
thalamus, the SC, DA neuron cell bodies, DA axons, and DA
presynaptic terminals largely encompasses 6* nAChR expres-
sion in the mammalian brain. Together, our data along with
previous findings suggest that 6* nAChRs may be uniquely
suited to mediate cholinergic sensitization of brain pathways im-
portant for recognizing and responding to unexpected and po-
tentially important sensory experiences. Although other nAChR
subunits are also expressed in some of these brain areas (Moretti
et al., 2004; Endo et al., 2005; Gotti et al., 2005; Cox et al., 2008),
this role for 6* nAChRs contrasts with the action of 4(non-
6)2* nAChRs, which are more widely expressed and may play
a more general—though still crucial—role in cholinergic sensiti-
zation of neural circuits. What advantage do 6 nAChR subunits
provide over nAChRs already containing 4 and 2 subunits?
6* nAChRs are among those with the highest sensitivity (Salmi-
nen et al., 2007), which could reflect the particular evolutionary
importance of reliably alerting and responding to novel, poten-
tially rewarding events in the environment. Additional studies are
required to fully explore the role 6* nAChRs at the intersection
of visual and DAergic systems.
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